MA09-hRPE

human embryonic stem cell-derived retinal pigment epithelium cells · Astellas Institute for Regenerative Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MA09-hRPE, covering 2024-10-31 to 2024-10-31. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration [Phase 1, Phase 2]

See pricing